Phibro Animal Health (PAHC) EBT Growth (3y) (2015 - 2026)
Phibro Animal Health (PAHC) EBT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 28.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.85% |
| Dec 31, 2025 | 44.35% |
| Sep 30, 2025 | 88.47% |
| Jun 30, 2025 | 24.46% |
| Mar 31, 2025 | 3.43% |
| Dec 31, 2024 | -40.98% |
| Sep 30, 2024 | 0.09% |
| Jun 30, 2024 | -54.59% |
| Mar 31, 2024 | -10.10% |
| Dec 31, 2023 | -39.44% |
| Sep 30, 2023 | -39.69% |
| Jun 30, 2023 | 35.85% |
| Mar 31, 2023 | -6.81% |
| Dec 31, 2022 | -10.51% |
| Sep 30, 2022 | 14.89% |
| Jun 30, 2022 | 21.59% |
| Mar 31, 2022 | 11.20% |
| Dec 31, 2021 | 5.44% |
| Sep 30, 2021 | -24.96% |
| Jun 30, 2021 | -11.83% |